Jeff Handler, VP of Safety Assessment
Professional Overview
Jeff Handler is the Vice President of Safety Assessment at Morphic Therapeutic, a leading biopharmaceutical company focused on developing innovative therapies for serious diseases. With over 15 years of experience in the pharmaceutical and biotech industries, Jeff is a respected expert in drug safety assessment, clinical operations, and regulatory affairs.
Experience Summary
Current Role
As Vice President of Safety Assessment at Morphic Therapeutic, Jeff is responsible for overseeing the planning, execution, and reporting of all safety-related activities across the company's drug development pipeline. He plays a key role in ensuring the safety and well-being of clinical trial participants, as well as compliance with regulatory guidelines. Under his leadership, Morphic has successfully navigated complex safety challenges, streamlining processes and implementing best-in-class risk mitigation strategies.
Career Progression
Prior to joining Morphic, Jeff served as the Chief Operating Officer at Eppin Pharma, where he was instrumental in advancing the company's lead product candidate through clinical trials and regulatory approval. He has also held senior positions at Melior Discovery and sanofi-aventis, where he gained extensive experience in drug discovery, preclinical development, and global product launch initiatives.
Throughout his career, Jeff has demonstrated a proven track record of driving operational excellence, fostering cross-functional collaboration, and delivering tangible results that have positively impacted patient outcomes and shareholder value.
Academic Background
Jeff holds a Bachelor of Science degree in Pharmaceutical Sciences from the University of Rhode Island, where he graduated with Honors. He is a respected thought leader in the industry and has authored numerous peer-reviewed publications and presentations on topics related to drug safety and clinical development.
Areas of Expertise
- Drug safety assessment and risk management
- Clinical trial design and operations
- Regulatory affairs and compliance
- Pharmaceutical product development and launch
- Cross-functional team leadership and collaboration
Professional Impact
Under Jeff's guidance, Morphic Therapeutic has successfully navigated complex safety challenges, streamlining processes and implementing best-in-class risk mitigation strategies. His leadership has been instrumental in the advancement of the company's drug development pipeline, contributing to the successful completion of multiple clinical trials and the achievement of key regulatory milestones.
Conclusion
With his extensive experience, robust technical expertise, and proven track record of success, Jeff Handler is a valuable asset to Morphic Therapeutic and the broader pharmaceutical industry. His unwavering commitment to patient safety and his ability to drive operational excellence make him a respected leader in the field of drug development and safety assessment.
